About Hôtel-Dieu de St Jérome
Clinical Trials at Hôtel-Dieu de St Jérome
During the past decade, Hôtel-Dieu de St Jérome conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hôtel-Dieu de St Jérome" #1 sponsor was "Bio-K Plus International Inc." with 1 trials, followed by "Boehringer Ingelheim" with 1 trials
sponsored, "Montreal Heart Institute" with 1 trials sponsored, "Ono Pharma USA Inc" with 1 trials sponsored and "Sanofi"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hôtel-Dieu de St Jérome"
#1 collaborator was "Bayer" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "JSS Medical Research Inc." with 1 trials as a collaborator and "Sorin Group Canada" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Hôtel-Dieu de St Jérome
According to Clinical.Site data, the most researched conditions in "Hôtel-Dieu de St Jérome" are
"Cerebrovascular Accident" (1 trials), "Clostridium Infections" (1 trials), "Diarrhea" (1 trials), "Hypertension" (1 trials) and "Patients With Pacemaker With Conduction Problems" (1 trials). Many other conditions were trialed in "Hôtel-Dieu de St Jérome" in a lesser frequency.
Clinical Trials Intervention Types at Hôtel-Dieu de St Jérome
Most popular intervention types in "Hôtel-Dieu de St Jérome" are "Drug" (3 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "(LMW)heparin" (1 trials), "Acenocoumarol VKA" (1 trials), "Lactobacillus acidophilus CL1285 and Lactobacillus casei" (1 trials), "ONO-2506" (1 trials) and "Pacing mode" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hôtel-Dieu de St Jérome
The vast majority of trials in "Hôtel-Dieu de St Jérome" are
5 trials for "All" genders.
Clinical Trials Status at Hôtel-Dieu de St Jérome
Currently, there are NaN active trials in "Hôtel-Dieu de St Jérome".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Hôtel-Dieu de St Jérome,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hôtel-Dieu de St Jérome, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".